Skip to content
Intrinsic Longevity
Wellness & vitality

CJC-1295 (without DAC)

Also known as: Modified GRF 1-29

A short-acting copy of the brain signal that tells the pituitary gland to release growth hormone in short bursts.

Class
Growth hormone releaser
Also called
Modified GRF 1-29
Duration
Short-acting
FDA status
Not FDA-approved
Overview

What it is

CJC-1295 without DAC, also called Modified GRF 1-29, is a lab-made copy of growth hormone-releasing hormone. The body clears it quickly, so its signal is short.

The natural brain signal for growth hormone breaks down within minutes. Researchers trimmed it to its first 29 amino acids and made small changes so it would survive longer, and that is Modified GRF 1-29.

The naming is genuinely confusing. CJC-1295 originally referred to the long-acting version. The short-acting one picked up the same name over time, so clinics add without DAC to tell them apart.

It is usually named alongside ipamorelin, because the two reach the pituitary gland through different receptors.

Benefits

What it supports

  • Supports lean muscle and post-training recovery through short growth hormone bursts
  • Supports body-composition goals tied to how the body uses fat
  • Supports sleep quality, energy, and daily vitality goals
  • Offers a shorter signal than the with-DAC version for people who prefer that pattern
Mechanism

How it works

1

The pituitary gland releases growth hormone in bursts, and the brain's releasing hormone is what triggers each burst.

2

This peptide copies that trigger. It binds the same receptors on the pituitary and prompts a burst of the gland's own growth hormone.

3

It clears within a few hours, so the signal comes and goes. That short pattern is closer to how the body does it naturally than a signal that stays on for days.

4

Growth hormone then raises IGF-1, and that pair is what the muscle, recovery, and body-composition claims are built on.

Context

Who it's for

Adults focused on lean muscle and recovery who prefer a short, pulse-like signal

People weighing the short-acting and long-acting CJC-1295 forms against each other

Adults looking at body composition through the growth hormone system

People trying to understand what the CJC-1295 / Ipamorelin name actually refers to

Landscape

In the landscape

How this compound compares to related options in the wellness landscape.

  • CJC-1295 (with DAC)

    The long-acting version, which attaches to a blood protein and stays active for days rather than hours.

  • Ipamorelin

    Reaches a different receptor in the same gland, which is why the two are often named together.

Questions

CJC-1295 (without DAC) FAQ

Good to know

Regulatory & considerations

CJC-1295 without DAC is not FDA-approved. That means the FDA has not reviewed it for safety or effectiveness for the uses described here. Published human data is limited to small early studies.

Peptides in our shop are sourced from US-licensed manufacturers.

CJC-1295 without DAC is not FDA-approved, and its status under pharmacy compounding rules is still being decided.

Raising growth hormone can affect blood sugar and can cause fluid retention or joint aches.

The short-acting and long-acting forms are not interchangeable. How long the signal lasts is the whole difference.

Shop CJC-1295 (without DAC)

See current pricing and availability for CJC-1295 (without DAC) in our shop. If a medical evaluation is needed, a licensed provider guides you through it.

Individual results vary. General information on this site is not a substitute for professional medical advice.